Crescentis Capital Limited Receives BSE In-Principle Approval for 13,00,000 ESOP Shares

1 min read     Updated on 04 Apr 2026, 12:32 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Crescentis Capital Limited has obtained BSE in-principle approval for issuing 13,00,000 equity shares under its Employee Stock Option Scheme 2025. The approval, dated April 02, 2026, covers shares with ₹10 face value each and comes with specific compliance conditions including regulatory notifications, fee payments, and statutory approvals that must be fulfilled before share allotment to employees.

powered bylight_fuzz_icon
36831756

*this image is generated using AI for illustrative purposes only.

Crescentis capital Limited has received in-principle approval from BSE Limited for issuing equity shares under its employee stock option scheme. The approval covers 13,00,000 equity shares with a face value of ₹10 each, to be issued under the "Crescentis Capital Limited Employees' Stock Option Scheme 2025".

BSE Approval Details

The BSE granted approval through letter reference DCS/ESOP/IP/RD/006/2026-27 dated April 02, 2026. The company informed BSE about receiving this approval on April 04, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Parameter Details
Approved Shares 13,00,000 equity shares
Face Value ₹10 per share
Scheme Name Crescentis Capital Limited Employees' Stock Option Scheme 2025
BSE Reference DCS/ESOP/IP/RD/006/2026-27
Approval Date April 02, 2026

Compliance Conditions

BSE has set several conditions that Crescentis Capital Limited must fulfill before the shares can be allotted:

  • Regulatory Notifications: The company must notify BSE as per Regulation 10(c) format after share allotment and crediting to beneficiaries' accounts
  • Fee Payments: Payment of prescribed fees from time to time
  • Statutory Approvals: Receipt of approvals from SEBI, RBI, MCA and other statutory authorities
  • Documentation: Submission of required documents as per BSE checklist
  • Legal Compliance: Adherence to Companies Act provisions and other applicable laws

Share Allotment Framework

The approved equity shares will be allotted to employees upon exercise of stock options under the Securities Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. BSE will issue trading permission from time to time upon receipt of proper notifications and compliance with stated conditions.

Company Background

Crescentis Capital Limited, formerly known as Som Datt Finance Corporation Limited, operates with CIN L65921TS1993PLC188494. The company is headquartered at JIVI Towers, Banjara Hills, Hyderabad, Telangana. V. V. Krishna Chaitanya serves as the Company Secretary and Compliance Officer.

BSE reserves the right to withdraw its in-principle approval if submitted information is found incomplete, incorrect, or misleading, or for any contravention of exchange rules and regulations.

Historical Stock Returns for Crescentis Capital

1 Day5 Days1 Month6 Months1 Year5 Years
-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%

What is the expected timeline for Crescentis Capital to fulfill all BSE compliance conditions and begin actual share allotments to employees?

How might this ESOP scheme impact Crescentis Capital's employee retention and recruitment strategy in the competitive financial services sector?

What percentage of the company's total equity will these 13 lakh shares represent, and how could this dilution affect existing shareholders?

Crescentis Capital Limited Files SEBI Disclosure Under Takeover Regulations for FY26

1 min read     Updated on 02 Apr 2026, 05:38 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Crescentis Capital Limited filed a regulatory disclosure with BSE Limited under SEBI Regulation 31(4) for FY26 ended March 31, 2026. The company confirmed that promoters and promoter group members made no share encumbrance, directly or indirectly, during the financial year. The disclosure was submitted on April 2, 2026, with proper authorization from company officials.

powered bylight_fuzz_icon
36677334

*this image is generated using AI for illustrative purposes only.

Crescentis capital Limited has filed a regulatory disclosure with BSE Limited under SEBI takeover regulations for the financial year ended March 31, 2026. The company, formerly known as Som Datt Finance Corporation Limited, submitted the mandatory filing on April 2, 2026.

Regulatory Disclosure Details

The disclosure was made pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. Company Secretary and Compliance Officer V V Krishna Chaitanya signed the submission letter addressed to BSE Limited's Corporate Relations Department.

Parameter: Details
Filing Date: April 2, 2026
Regulation: SEBI Regulation 31(4)
Financial Year: Ended March 31, 2026
Scrip Code: 511571
CIN: L65921TS1993PLC188494

Promoter Group Declaration

The promoters and promoter group members submitted a formal declaration regarding share encumbrance activities during FY26. Bhavanam Ruthvik Reddy, serving as the authorized signatory, signed the declaration on behalf of the promoter and promoter group.

The key disclosure confirmed that:

  • No encumbrance of shares was made by promoters during FY26
  • No indirect share encumbrance occurred through promoter group members
  • The declaration covers the complete financial year ended March 31, 2026

Corporate Information

Crescentis Capital Limited operates from its registered office at JIVI Towers, Road No 7, Banjara Hills, Hyderabad, Telangana. The company maintains its listing on BSE Limited under scrip code 511571. The filing demonstrates the company's adherence to SEBI's substantial acquisition and takeover disclosure requirements, ensuring transparency in promoter shareholding activities.

Historical Stock Returns for Crescentis Capital

1 Day5 Days1 Month6 Months1 Year5 Years
-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%

What strategic initiatives might Crescentis Capital pursue in FY27 that could impact their promoter shareholding structure?

Will the company's clean encumbrance record attract potential institutional investors or strategic partners in the coming quarters?

How might changes in SEBI's takeover regulations affect Crescentis Capital's future disclosure requirements and compliance costs?

More News on Crescentis Capital

1 Year Returns:-100.00%